Crossref
Switching frail older people with AF from a vitamin K antagonist to a DOAC
Drug and Therapeutics Bulletin · 2024
DOI: 10.1136/dtb.2024.000037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug and Therapeutics Bulletin, 2024. Hauptthemen laut MEDLINE: Atrial Fibrillation, Vitamin K, Frail Elderly. Die Arbeit nennt 4 Literaturangaben.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
. Safety of switching from a vitamin K antagonist to a non-vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomised controlled trial
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Atrial FibrillationVitamin KFrail ElderlyHumansAgedFactor Xa InhibitorsAnticoagulantsAged, 80 and overDrug Substitution
Stichwörter der Autor:innen
Drug-Related Side Effects and Adverse ReactionsHealth Care Quality, Access, and Evaluation
Substanzen
Vitamin KFactor Xa InhibitorsAnticoagulants
Zitieren
APA
(2024). Switching frail older people with AF from a vitamin K antagonist to a DOAC. Drug and Therapeutics Bulletin. https://doi.org/10.1136/dtb.2024.000037
Vancouver
Switching frail older people with AF from a vitamin K antagonist to a DOAC. Drug and Therapeutics Bulletin. 2024. doi:10.1136/dtb.2024.000037
BibTeX
@article{euvimed2024,
title = {Switching frail older people with AF from a vitamin K antagonist to a DOAC},
journal = {Drug and Therapeutics Bulletin},
year = {2024},
doi = {10.1136/dtb.2024.000037}
}
EUVIMED